Boston Scientific (BSX) Non-Current Debt (2009 - 2026)
Boston Scientific (BSX) posted quarterly Non-Current Debt of $10.9 billion for Q2 2026, up 2083.0% year-over-year from $500.0 million in Q2 2025, and down 0.66% on a QoQ basis from $11.0 billion in Q1 2026.
Boston Scientific (BSX) Non-Current Debt (2009 - 2026) Analysis & Trends
Boston Scientific has reported Non-Current Debt for 18 years, with the latest figure at $10.9 billion in Q2 2026.
- Non-Current Debt for Q2 2026 came in at $10.9 billion, up 2083.0% year-over-year; the trailing twelve-month figure through Jun 2026 was $10.9 billion (up 2083.0% YoY), and the FY2025 annual result was $11.1 billion, up 24.19% from the prior year.
- Non-Current Debt eased to $10.9 billion in Q2 2026, from $11.0 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $11.1 billion in Q4 2025 and troughed at $500.0 million in Q2 2025.
- A 5-year average of $8.3 billion and a median of $8.9 billion in 2022 frame the typical range for Non-Current Debt.
- The widest annual swing landed in 2025, when Non-Current Debt tumbled 94.44%; it then jumped 2083.0% in 2026.
- A 5-year view of Non-Current Debt shows it stood at $3.3 billion in 2022, then surged by 161.71% to $8.6 billion in 2023, then rose by 4.63% to $9.0 billion in 2024, then climbed by 24.19% to $11.1 billion in 2025, then declined by 1.99% to $10.9 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $10.9 billion in Q2 2026, $11.0 billion in Q1 2026, and $11.1 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 6.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.92 Bn |
| Mar 31, 2026 | 10.99 Bn |
| Dec 31, 2025 | 11.14 Bn |
| Sep 30, 2025 | 11.12 Bn |
| Jun 30, 2025 | 500.00 Mn |
| Mar 31, 2025 | 10.53 Bn |
| Dec 31, 2024 | 8.97 Bn |
| Sep 30, 2024 | 9.23 Bn |
| Jun 30, 2024 | 8.99 Bn |
| Mar 31, 2024 | 9.53 Bn |
| Dec 31, 2023 | 8.57 Bn |
| Sep 30, 2023 | 8.39 Bn |
| Jun 30, 2023 | 8.49 Bn |
| Mar 31, 2023 | 8.50 Bn |
| Dec 31, 2022 | 3.28 Bn |
| Sep 30, 2022 | 8.56 Bn |
| Jun 30, 2022 | 8.80 Bn |
| Mar 31, 2022 | 3.28 Bn |
| Dec 31, 2021 | 8.80 Bn |
| Sep 30, 2021 | 8.82 Bn |